BioNTech SE (BNTX)

NasdaqGS • Currently down 1.90 (-2.08%) in today's trading session

2 members of Congress have disclosed 5 trades in BioNTech SE (BNTX) via STOCK Act filings. The most recent disclosure was a purchase by Lucia Kay McBath on 21 August 2025. The most active traders have been Josh Gottheimer (3) and Lucia Kay McBath (2). Aggregate disclosed activity totals roughly $32K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

BioNTech SE is currently trading at $89.39, positioned at 22% of its 52-week range ($79.52 – $124.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$89.39
24h Change
-1.90 (-2.08%)
52 Week Range
$79.52–$124.00
View on NASDAQ

BioNTech SE Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BNTX

Select to highlight on chart
5 transactions
Compliance: 60%
Lucia Kay McBath21 Aug 202511 Sept 2026PurchaseStock$1,001 - $15,000N/A
Lucia Kay McBath25 Jul 202511 Sept 2026SaleStock$1,001 - $15,000N/A
Josh Gottheimer7 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer6 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer5 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$22.49B

Volume

823.29K

Beta

1.25

P/E Ratio

-11.61

Fundamentals

EPS

$-7.71

Div. Yield

-

Open

$90.75

Day Range

$89.05 – $92.73

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
DE
CEO
Ugur Sahin
IPO Date
2019-10-10
Website
www.biontech.com/de/de/home.html

BioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. A significant part of its oncology pipeline includes the FixVac cancer vaccine program, which fe...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$0.85

Rev. Est.

$1.2B

Days Until

12

Recent Quarters

Q2 20264 Aug
EPS$-3.70
Miss 54.3%
Q1 20265 May
EPS$-2.43
Beat 4.4%
Q4 202510 Mar
EPS$-1.44
Miss 556.7%
Q3 20253 Nov
EPS$-0.14
Beat 87.5%
Q2 20254 Aug
EPS$-1.82
Beat 32.3%
Q1 20255 May
EPS$-1.82
Beat 26.6%
Q4 202410 Mar
EPS$1.15
Beat 148.7%
Q3 20244 Nov
EPS$0.89
Beat 151.1%
Q2 20245 Aug
EPS$-3.62
Miss 65.2%
Q1 20246 May
EPS$-1.42
Miss 5.8%
Q4 202320 Mar
EPS$2.05
Miss 21.8%
Q3 20236 Nov
EPS$0.73
Beat 217.0%
Q2 20237 Aug
EPS$-0.86
Beat 5.4%
Q1 20238 May
EPS$2.20
Beat 665.8%
Q4 202227 Mar
EPS$9.46
Beat 13.7%
Q3 20227 Nov
EPS$7.04
Beat 110.2%
Q2 20228 Aug
EPS$7.31
Miss 1.5%
Q1 20229 May
EPS$15.98
Beat 57.6%
Q4 202130 Mar
EPS$13.93
Beat 64.7%
Q3 20219 Nov
EPS$14.56
Beat 23.5%
Q2 20219 Aug
EPS$12.98
Beat 55.5%
Q1 202110 May
EPS$5.29
Beat 22.7%
Q4 202030 Mar
EPS$1.87
Beat 428.1%
Q3 202010 Nov
EPS$-1.03
Miss 123.9%
Q2 202011 Aug
EPS$-0.42
Miss 44.8%
Q1 202012 May
EPS$-0.26
Beat 13.3%
Q3 201931 Dec
EPS$-0.29
Q3 201914 Nov
EPS$-0.16
Beat 23.8%
Q1 201930 Jun
EPS$-0.25
Q4 201831 Mar
EPS$-0.20
Q3 201831 Dec
EPS$-0.01
Q2 201830 Sept
EPS$-0.12
Q1 201830 Jun
EPS$-0.07
Q4 201731 Mar
EPS$-0.07

1 politician traded within 30 days

Dividends

Dividend History

2 Jun 2022
Amount $2.1110

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MSFT

Microsoft Corporation

69
$522.00-10.96 (-2.06%)
Technology
2 politicians both hold this
$36M in total holdings
2 politicians
View Stock

GOOG

Alphabet Inc.

47
$319.80-11.15 (-3.37%)
Communication Services
2 politicians both hold this
Significant holdings value
2 politicians
View Stock

NVDA

NVIDIA Corporation

47
$212.19-9.78 (-4.41%)
Technology
2 politicians both hold this
Significant holdings value
2 politicians
View Stock

Frequently Asked Questions about BNTX

Which members of Congress have traded BNTX?
2 members of Congress have disclosed 5 trades in BioNTech SE (BNTX) under the STOCK Act. The most active traders are Josh Gottheimer and Lucia Kay McBath.
When was BNTX most recently disclosed by Congress?
The most recent BNTX disclosure was a purchase by Lucia Kay McBath on 21 August 2025.
What is the total disclosed congressional trading volume for BNTX?
Members of Congress have disclosed approximately $32K in BNTX purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BNTX?
This BNTX page updates as soon as new STOCK Act disclosures are filed for BioNTech SE. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.